chrisvoncsefalvay/vaers-outcomes huggingface dataset:
PATIENT RECEIVED PFIZER DOSE AS 2ND DOSE WHEN THEY RECEIVED MODERNA AS THEIR 1ST ON 9/6/21. NO SIDE EFFECTS SO FAR. PATIENT WAS WITH YOUNGER SIBLING WHO HAD PFIZER GIVEN. PHARMACY TECH TRAINED TO VACCINATE DID NOT CLARIFY AND GAVE INCORRECT VACCINE. PATIENT WAS CONTACTED IMMEDIATELY AFTER AND INFORMED OF SITUATION AND BEST KNOWN INFORMATION AT THE TIME (THAT VACCINE COMPLETES THE SERIES)
redness, swelling, pain 22hr p/vax;inc day by day;saw MD 17APR;rx tapering dose pred 5 days;improved 20APR;comfort measures-cold, wet compress;pain med;
Recent CAT scan shows ground glass opacities not seen in 4q19.  No previous COVID infection.
Tiredness, head ache, weakness, low pressure, dizziness, nausea, heart beat  abruptly changes.
Evening of vaccination, mom noticed hives on left leg from mid shin to hip. Fever started on 11/8/18 (in the evening) and resolved after 48 hours. Tmax 103. Mom gave TYLENOL for fever. Symptoms self resolved.
right after the vaccination I had headaches not that severe but that was it and then months later I found something weird on my body. I contacted my doctor and they ran some tests. I weighted for a while and then got serious about it and went to the neurologist and they said i had a lump on my testicles and then i got an ultrasound and they said it was an inflamed  lump. It was epidemies, i went to the second neurologist and they told me i do not need any ultrasound and he said it was inflammation.
Tried all the time, not eating, anemia, stopped making blood, hospitalized from may 21, 2021 to dying on June 29, 2021with ANCA  vasculitis  renal failure.  My mother was never sick with this until She got the vaccine moderna
Very high glucose + 300 with need for more than 10 extra units insulin per day for 4 days; Diarrhea; Vomiting day 4 to day 6; Continuing nausea; Continuing nausea with loss of 5 lbs; This is a spontaneous report from a contactable consumer (patient). An 80-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EM9810), via an unspecified route of administration, right arm on 14Feb2021 12:15 PM at single dose for covid-19 immunisation at Doctor's office/urgent care. The patient wasn't pregnant at the time of vaccination. The patient's medical history included Allergies to medications, food, or other products included Sulfa, gluten and cortisone meds, diabetes since age 5 and heart failure. List of any other medications the patient received within 2 weeks of vaccination included Thyroid, metoprolol succinate (TOPROL XL), KCL, furosemide (LASIX [FUROSEMIDE]) (reported as Lasux), spironolactone. The patient didn't received any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced very high glucose + 300 with need for more than 10 extra units insulin per day for 4 days on 17Feb2021 12:00 PM, diarrhea and vomiting day 4 to day 6 and now continuing nausea with loss of 5 lbs because of nausea at day 11 on Feb2021. The patient received additional insulin as a treatment and call to cardiac physician. Prior to vaccination, the patient wasn't diagnosed with COVID-19. Since the vaccination, the patient hasn't been tested for COVID-19. The outcome of the event Blood glucose increased, Diarrhea, Vomiting, Weight loss was recovering and outcome of event Nausea was not recovered.  Information regarding lot/batch number has been requested.
Lymph Nodes swollen for 2 weeks follow by a cough & hoarse voice, chest pain, left ear felt clogged, Light bleeding from the retina for 2 days. Abdominal pain. Arm swollen for 1 week and skin itchy from where the shot was administrator.
Headache, fuzziness, and overall weakness that kept me in bed for 1 1/2 days. No fever. Took Tylenol and Metamizole..
Palpitation; Heart was acting erratically; Numbness on the left side; Puffiness on the left side; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 04-Jun-2021 and was forwarded to Moderna on 04-Jun-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (Palpitation), HEART RATE ABNORMAL (Heart was acting erratically), HYPOAESTHESIA (Numbness on the left side) and SWELLING (Puffiness on the left side) in a 25-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 01-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-May-2021 at 10:00 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 29-May-2021, the patient experienced PALPITATIONS (Palpitation) (seriousness criterion hospitalization), HEART RATE ABNORMAL (Heart was acting erratically) (seriousness criterion hospitalization), HYPOAESTHESIA (Numbness on the left side) (seriousness criterion hospitalization) and SWELLING (Puffiness on the left side) (seriousness criterion hospitalization). The patient was treated with LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) at a dose of 1once a day; IBUPROFEN (ADVIL 12 HOUR) on 29-May-2021 at a dose of 1 UNK and PARACETAMOL (TYLENOL) from 29-May-2021 to 30-May-2021 at a dose of 1 UNK. At the time of the report, PALPITATIONS (Palpitation), HEART RATE ABNORMAL (Heart was acting erratically), HYPOAESTHESIA (Numbness on the left side) and SWELLING (Puffiness on the left side) had not resolved.            No relevant concomitant medications were  provided. The reporter was in contact with physician and also went to emergency room (ER) but they were not able to resolve the problem. The reporter confirmed that these side effects were still going on. Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Reddness of skin, itching, tightness in chest, shortness of breath within 15 minutes. Was not reported until after going to ER 4 hrs later. Recieved Benadryl, steroid injection, & breathing tx at ER and then was okay. Reports she aleays has these type of reactions when taking any medication including her routine insulin she takes. 12/11/09 ED records received for DOS 11/24/09. Pt presented with SOB, rash on chest following vaccination 15 minutes earlier. Treated with benadryl, solu-medrol and nebulizer. Discharged stable with Rx. for prednisone. DX: Allergic reaction
Arm weakness/Weakness all over the hand; Arm pain/The pain is from her shoulders extending to her fingertips; The pain is from her shoulders extending to her fingertips.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 36 year-old female patient received bnt162b2 (BNT162B2), administration date 30Oct2021 11:30 (Lot number: FFZ588) at the age of 36 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Asthma" (unspecified if ongoing); "Hypothyroidism" (unspecified if ongoing), notes: about 7 years ago. Concomitant medication(s) included: LEVOTHYROXINE taken for hypothyroidism. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE), for COVID-19 immunization; Bnt162b2 (DOSE 2, SINGLE), for COVID-19 immunization. The following information was reported: MUSCULAR WEAKNESS (non-serious) with onset 2021, outcome "not recovered", described as "Arm weakness/Weakness all over the hand"; PAIN IN EXTREMITY (non-serious) with onset 2021, outcome "not recovered", described as "Arm pain/The pain is from her shoulders extending to her fingertips"; ARTHRALGIA (non-serious) with onset 2021, outcome "not recovered", described as "The pain is from her shoulders extending to her fingertips.". Therapeutic measures were taken as a result of muscular weakness, pain in extremity, arthralgia.   Additional information: The patient stated she received Ibuprofen for her pain. She said that the pain only goes away after taking Ibuprofen but comes back when it wears off. The patient received vaccine on the left.   No follow-up attempts are possible. No further information is expected.
This spontaneous report was received from a nurse refers to multiple unspecified patients of unknown gender and age. Information regarding patients' medical history, concurrent condition, drug reactions/allergies and concomitant therapy were not provided. On unknown dates, these patients were vaccinated with improperly stored MMR II (lot # K006396, expiry date: 04-MAY-2016). Reporting nurse stated that the vaccine underwent a temperature excursion of 49.6 degree Fahrenheit for 1 hour and 17 minutes. No adverse effects were reported. Additional information has been requested.
Pain at injection site only lasted an hour. Nausea started about 20 minutes after injection and increasing got worse through the day accompanied by a severe headache. Day 2 Nausea was still present but not as severe although headache remained.
BREAKTHROUGH CASE AS WELL; SUSPECTED CLINICAL VACCINATION FAILURE; This spontaneous report received from a consumer concerned a male of unspecified age, race and ethnicity.  The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) 1 total, dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the patient experienced breakthrough case as well, and suspected clinical vaccination failure. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the breakthrough case as well and suspected clinical vaccination failure was not reported. This report was serious (Other Medically Important Condition). This report was associated with regulatory authority:90000200150. This case, from the same reporter is linked to 20211103834.; Sender's Comments: V0: 20211102956 -covid-19 vaccine ad26.cov2.s- breakthrough case as well This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).  20211102956-COVID-19 VACCINE AD26.COV2.S-suspected clinical vaccine failure. This event is considered not related. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event than the drug. Specifically: SPECIAL SITUATIONS.
Swollen very swollen and red lymph nodes under armpit unable to use arm due to pain and swelling
head felt heavy; chills; Headache; Fever; This is a spontaneous report from a contactable consumer (patient). A 52-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 21Dec2020 at a single dose for COVID-19 immunization. There were no relevant medical history and concomitant medications.  On 21Dec2020, the patient had the Covid-19 vaccine yesterday and experienced reactions. She works at the hospital and was administered the vaccine. They have to wait and be monitored for 15 minutes following the vaccine. Ten minutes after she had the vaccine her head felt heavy. She said she would be ok. Her blood pressure and oxygen sats were checked. Then she had a fever of 100.4. She also had chills and a headache that came back later in the day and she took acetaminophen. She had chills and a fever of 101.4 again at the time of report (22Dec2020). She had not taken any acetaminophen at the time of report. She does not have any shortness of breath. The patient recovered from the event head felt heavy and headache, while not recovered for chills and fever.   Information on the lot/batch number has been requested.
A previously diluted, used, and since expired vial of Pfizer Covid vaccine was rediluted and a dose of 0.3ml was administered. Pfizer was contacted for inappropriate administration guidance.  A voicemail was left for the patient asking for a return phone call. At this time, it is not recommended to have the patient repeat the 2nd dose. If the patient returns our call, she will be advised to monitor for adverse reactions including infection at the injection site.
Started w/"wheezing cough" - 10/12/14 vomited x 1-10/13/14- Office visit 10/14/14- dx: acute asthma exacerbation- PEF (160) tx: prednisolone, albuterol MDI- OV to recheck scheduled for 10/17/14.
Migraine, vomiting, diarrhea. On 11/20 ended up in ER with tachycardia & hypertension.
Patient is a 72 y.o. female with history of Lewy body dementia who presented from home on 3/14/2023 with acute hypoxemic respiratory failure and found to be COVID-positive with superimposed bacterial pneumonia.  Patient had a prolonged hospital course due to acute on chronic encephalopathy, severe sepsis and aspiration pneumonia.  She was intubated while in ICU, unable to wean. Family opted for DNR CC after GOC discussions with Palliative team.  Patient was discharged to the inpatient hospice team at a local HCF.   Acute hypoxic respiratory failure COVID infection Aspiration pneumonia Septic shock -Patient was admitted for hypoxemia and found to have COVID-positive infection.  -Transferred to ICU, intubated.  Hospital course was prolonged due to inability to wean, acute on chronic encephalopathy -Patient was extubated after extensive goals of care discussion with palliative team.  Patient is currently DNR CC   Lewy body dementia Acute on chronic encephalopathy -Known history, she is currently obtunded -Comfort meds in place   Essential hypertension -She needed vasopressor support for septic shock while in ICU -Home Coreg held
Patient had lower leg cramps, mainly at night; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (Patient had lower leg cramps, mainly at night) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Apr-2021, the patient experienced MUSCLE SPASMS (Patient had lower leg cramps, mainly at night). At the time of the report, MUSCLE SPASMS (Patient had lower leg cramps, mainly at night) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported by the reporter. No treatment was reported by the reporter. Patient had second dose of Moderna COVID-19 Vaccine on 25-May-2021, Lot 019107A.
malaise; chills; red rash all over body; brain fog; Body aches; felt like worst flu ever; heart racing and slowing down; Headache; arm soreness; This spontaneous case was reported by a patient and describes the occurrence of INFLUENZA (felt like worst flu ever), HEART RATE (heart racing and slowing down), CHRONIC FATIGUE SYNDROME (brain fog), PAIN (Body aches) and PAIN IN EXTREMITY (arm soreness) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031A21A and 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concurrent medical conditions included Penicillin allergy and Allergy to antibiotic (omaxacillin ,tetracycline, erythromycin). Concomitant products included PRAVASTATIN for Cholesterol, BISOPROLOL for Heart rate, ENALAPRIL MALEATE, HYDROCHLOROTHIAZIDE (VASOPRIL PLUS), ATORVASTATIN and ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication.   On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Subcutaneous) 1 dosage form. On 15-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Subcutaneous) dosage was changed to 1 dosage form. On 16-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm soreness). On 16-Mar-2021, the patient experienced INFLUENZA (felt like worst flu ever), HEART RATE (heart racing and slowing down), PAIN (Body aches) and HEADACHE (Headache). On 18-Mar-2021, the patient experienced CHRONIC FATIGUE SYNDROME (brain fog) and RASH (red rash all over body). On an unknown date, the patient experienced MALAISE (malaise) and CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form; IBUPROFEN (ADVIL [IBUPROFEN]) at a dose of 1 dosage form and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of 1 dosage form. On 18-Feb-2021, PAIN IN EXTREMITY (arm soreness) had resolved. On 17-Mar-2021, INFLUENZA (felt like worst flu ever), HEART RATE (heart racing and slowing down), PAIN (Body aches) and HEADACHE (Headache) had resolved. At the time of the report, CHRONIC FATIGUE SYNDROME (brain fog), MALAISE (malaise) and CHILLS (chills) was resolving and RASH (red rash all over body) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101.4 (Inconclusive) 101.4.         This case was linked to MOD-2021-049485 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 25-Jul-2021: significant follow-up :-  concomitant medications, treatment medications, lab data and events updated.
Achy after 2nd dose; Feels run down after 2nd dose; Headache after 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Achy after 2nd dose), DEPRESSED MOOD (Feels run down after 2nd dose) and HEADACHE (Headache after 2nd dose) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN (Achy after 2nd dose), DEPRESSED MOOD (Feels run down after 2nd dose) and HEADACHE (Headache after 2nd dose). At the time of the report, PAIN (Achy after 2nd dose), DEPRESSED MOOD (Feels run down after 2nd dose) and HEADACHE (Headache after 2nd dose) outcome was unknown.            no treatment information provided. Concomitant medications were not reported
7.5 hours after receiving vaccine noted fever 103, body aches, lightheaded was, pruritus, palpitations and mild sensation that throat was swelling.. eventually noted rash on torso. Had fever for several days, dyspnea and fatigue. No treatment was given beyond antipyretics.
Pfizer COVID vaccine #3 given 9/29/21, lot # FC3182; 1/29/22 pt brought to ED via EMS with cough, wheezing, increasing SOB; sx started 2 days prior; O2 supplementation; dexamethasone, baricitinib; ICU; eventually required ventilator support; pneumonia; Pseudomonas pneumonia enterococcal infection; hypertensive; family requested palliative extubation; extubated on 2/21/22 and she passed away on 2/24/22 in the hospital
Rash similar to hives. Tuesday very severe muscle stiff, could not move leg, Tuesday evening very stiff pains in other let, spread to hands, arms and feet by the next day, high blood pressure.  Arms and hands feel as though there is nerve pain.
Patient receiving flu shot, first attempted and patient tensed up, so had to re-stick patient. Upon receiving vaccine, patient passed out and then regained consciousness within a few seconds. Patient felt very dizzy, EMS was contacted and arrived shortly after. Patient's blood pressure was taken and vitals were okay. EMS did complete a patient work up, but did not feel he needed to go to the ER. Patient was able to walk out of the store and mom was taking patient to urgent care.
Fever 105.1F-10 hours after vaccination.  Seen at ER-CXR and blood cultures- neg.  IV fluids given.  Temp down.  Next am (2/20/03) temp 103F, seen by pvt MD. Tx with antibotic for pharyngitis.  Dr. Advised to continue vaccines
fluzone high dose quadrivalent was given to a patient under 65 of age with no reported adverse event; Initial information received on 15-Nov-2023 regarding an unsolicited valid  non-serious case received from a physician.  This case involves a patient under 65 years of age who was given Influenza Quadrival A-B High Dose HV Vaccine[Fluzone high-Dose Quadrivalent] with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient under 65 years age received a dose of suspect Influenza Quadrival A-B High Dose HV Vaccine (lot number, strength, expiry date, dose not reported) via unknown route in unknown administration site as immunization with no reported adverse event (product administered to patient of inappropriate age) (latency: same day).   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive and Regulatory Authority Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Mild Acute Demyelinating Polyneuropathy symptoms developed 1-2 wks after flu shot 10/15/2010.
on 6th day (not including the day of injection) after vaccination, pt developed swollen tongue and itching body rash. pt went to doctor who gave rx for benadryl & epi-pen.  although not completely resolved, taking benadryl helping  with symptoms. pt  did not have to use epi-pen yet.